Physician

Rakesh Kumar Bagai, M.D.

According to 2025 Medicare claims, Rakesh Bagai, M.D. (NPI: 1114182888) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is IRONWOOD PHYSICIANS, PC (NPI: 1740269299; TIN: 731636831) and primary practice location at 85260-6746. Bagai is affiliated with the Commonwealth Primary Care ACO LLC (ACO ID: D0224), participating under the REACH model.

Bagai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 862 traditional Medicare patients, billed 336,826 HCPCS/CPT codes, and received $5,425,971 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 1,332 prescription claims across 283 beneficiaries totaling $1,488,076 in drug costs, led by Lenalidomide (Lenalidomide). 2022 DME data shows 34 claims. Open Payments data shows 158 records totaling $9,613. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,911,450 to $5,425,971. Similarly, Part D prescription costs have risen steadily, from $18,284 to $1,488,076. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	426	182,978	$1,911,450
2016	521	313,227	$2,996,548
2017	525	301,336	$3,686,594
2018	499	276,320	$4,020,052
2019	530	327,215	$5,216,893
2020	536	250,454	$4,701,155
2021	573	309,724	$5,253,995
2022	827	336,258	$5,234,546
2023	934	429,993	$6,830,402
2024	862	336,826	$5,425,971

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	44	106	$18,284
2016	116	497	$386,170
2017	176	786	$334,161
2018	213	1,088	$583,176
2019	235	1,022	$871,056
2020	240	1,255	$1,018,913
2021	249	1,146	$1,498,598
2022	282	1,226	$1,381,583
2023	325	1,597	$1,332,118
2024	283	1,332	$1,488,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	28	$2,673
2018	N/R	N/R	N/R
2019	N/R	73	$7,006
2020	N/R	13	$2,493
2021	N/R	N/R	N/R
2022	N/R	34	$2,112
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	140	181	$1,148
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	173	216	$281
96413	Administration of chemotherapy into vein, 1 hour or less	137	944	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	539	1,294	$64
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	142	17,429	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	27	714	$332,123
Tagrisso	Osimertinib Mesylate	14	420	$237,144
Xtandi	Enzalutamide	11	330	$137,089
Eliquis	Apixaban	102	4,963	$97,765
Abiraterone Acetate	Abiraterone Acetate	33	990	$95,462

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	158	$9,613	Ipsen Biopharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rakesh Kumar Bagai, M.D.?

Tedicare shows public-source Medicare data for Rakesh Kumar Bagai, M.D. (NPI 1114182888), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rakesh Kumar Bagai, M.D. have ACO affiliation data?

Rakesh Kumar Bagai, M.D. is shown with ACO affiliation data for Commonwealth Primary Care ACO LLC (REACH, ACO ID D0224).

What billing organization is linked to Rakesh Kumar Bagai, M.D.?

Rakesh Kumar Bagai, M.D. is linked to IRONWOOD PHYSICIANS, PC (billing NPI 1740269299) in the available physician profile data.

Does Rakesh Kumar Bagai, M.D. have Open Payments data?

Rakesh Kumar Bagai, M.D. has 158 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.